| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 386,455 | 361,161 | 437,109 | 491,796 | | Cost of Revenue | 215,674 | 197,268 | 222,465 | 235,469 | | | Gross Profit | 170,781 | 163,893 | 214,644 | 256,327 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 63,425 | 60,283 | 64,986 | 78,173 | | Non Recurring |
-
| 92,683 |
-
|
-
| | Others | 52,720 | 50,978 | 49,868 | 46,825 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 54,636 | (40,051) | 99,790 | 131,329 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36,486 | (36,486) |
-
| (1,002) | | Earnings Before Interest And Taxes | 50,475 | (95,963) | 102,046 | 135,341 | | Interest Expense | 12,320 | 11,720 | 13,288 | 7,754 | | Income Before Tax | 38,155 | (107,683) | 88,758 | 127,587 | | Income Tax Expense | 13,736 | (38,766) | 31,953 | 41,741 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (33,398) | (68,917) | 56,805 | 85,846 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,419 | (68,917) | 56,805 | 85,846 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,419 | ($68,917) | $56,805 | $85,846 |
|
1.48% Nasdaq 
Income Statement
